| Autor: |
Blackstone, Erwin A., Fuhr Jr, Joseph P., Lawless, Grant D. |
| Zdroj: |
American Health & Drug Benefits; Sep/Oct2013, Vol. 6 Issue 8, p469-478, 10p, 2 Charts |
| Abstrakt: |
The article discusses opportunities and challenges being faced by the biosimilar manufacturing industry in the European Union (EU) region and the U.S. It offers details on pricing issues in the pharmaceuticals sector, the implementation of the U.S. federal legislation Biologics Price Competition and Innovation Act (BPCIA) of 2009, and the approval of biosimilars by the U.S. Food and Drug Administration (FDA). A brief overview of the availability of biosimilar products in the EU is presented. INSET: Modeling the Future Economic Impact of Biosimilars¿ Entry into.... |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
